The end of a shortage of popular weight-loss drugs may mean many people lose access to them
The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...
Medical News Today3h
GLP-1 drugs like Ozempic may protect brain health, several studies show
A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...
pharmaphorum22h
The Ozempic dilemma: Balancing demand, supply, and patient safety in a viral GLP-1 world
As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.